Your browser doesn't support javascript.
loading
A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer.
Seo, Seyoung; Keam, Bhumsuk; Shin, Seong Hoon; Chae, Yee Soo; Kim, Tae Min; Park, Lee Chun; Hong, Seung-Beom; Ahn, Myung-Ju; Kim, Sung-Bae.
Afiliação
  • Seo S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Shin SH; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea.
  • Chae YS; Department of Oncology/Hematology, Kyungpook National University Medical Center Biobank, Daegu, Republic of Korea.
  • Kim TM; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Park LC; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea.
  • Hong SB; Research Center, ISU ABXIS Co., Ltd., Seongnam, Republic of Korea.
  • Ahn MJ; Department of Hematology/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Int J Cancer ; 153(8): 1501-1511, 2023 10 15.
Article em En | MEDLINE | ID: mdl-37357950
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Cabeça e Pescoço / Antineoplásicos Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2023 Tipo de documento: Article